Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17β-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity.

Original publication

DOI

10.1021/jm200483x

Type

Journal article

Journal

J Med Chem

Publication Date

14/07/2011

Volume

54

Pages

4863 - 4879

Keywords

Angiogenesis Inhibitors, Animals, Antineoplastic Agents, Cell Line, Tumor, Collagen, Drug Combinations, Drug Screening Assays, Antitumor, Estradiol, Female, Humans, Laminin, Mice, Mice, Inbred C57BL, Neovascularization, Physiologic, Nitriles, Proteoglycans, Structure-Activity Relationship, Sulfonic Acids